ConductScience.org, home

Paper7584501

Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).

Hurez V and 6 others. Ther Immunol, 1994. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg). Papers, record 7584501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7584501

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).
PubMed
Journal
Ther Immunol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
2.45
iCite
Revised in PubMed
2022-03-17
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hurez VV
2Kaveri SVS V
3Mouhoub AA
4Dietrich GG
5Mani JCJ C
6Klatzmann DD
7Kazatchkine MDM D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4 AntigensMajor topic
Immunoglobulins, IntravenousMajor topic
Adjuvants, Immunologic
Blotting, Western
Fluorescent Antibody Technique, Direct
HIV Infections
HIV-1
Humans
Immunoassay
Lymphocyte Culture Test, Mixed
Protein Binding

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
37681862Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation.Cells2023https://conductscience.org/library/papers/37681862PubMed
36248801Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system.Front Immunol2022https://conductscience.org/library/papers/36248801PubMed
36134954Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.Antibodies (Basel)2022https://conductscience.org/library/papers/36134954PubMed
34205517Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.Vaccines (Basel)2021https://conductscience.org/library/papers/34205517PubMed
29692668Immune modulation of i.v. immunoglobulin in women with reproductive failure.Reprod Med Biol2018https://conductscience.org/library/papers/29692668PubMed
27193040An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques.Clin Vaccine Immunol2016https://conductscience.org/library/papers/27193040PubMed
26885437Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses.Int J Inflam2016https://conductscience.org/library/papers/26885437PubMed
26085909Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.World J Hepatol2015https://conductscience.org/library/papers/26085909PubMed
25284845Biologics in dermatology: an integrated review.Indian J Dermatol2014https://conductscience.org/library/papers/25284845PubMed
24889882
Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.
Clin Exp Immunol2014https://conductscience.org/library/papers/24889882PubMed
23304051Low-dose rituximab therapy for antibody-mediated rejection in a highly sensitized heart-transplant recipient.Tex Heart Inst J2012https://conductscience.org/library/papers/23304051PubMed
20514213Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Curr Neuropharmacol2009https://conductscience.org/library/papers/20514213PubMed
19879656Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.J Neuroimmunol2009https://conductscience.org/library/papers/19879656PubMed
19479057Optimization of immunoglobulin substitution therapy by a stochastic immune response model.PLoS One2009https://conductscience.org/library/papers/19479057PubMed
17351760Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.J Clin Immunol2007https://conductscience.org/library/papers/17351760PubMed
16998749Basic principles of intravenous immunoglobulin (IVIg) treatment.J Neurol2006https://conductscience.org/library/papers/16998749PubMed
16391400Intravenous immunoglobulin and multiple sclerosis.Clin Rev Allergy Immunol2005https://conductscience.org/library/papers/16391400PubMed
16178850Clinical uses of intravenous immunoglobulin.Clin Exp Immunol2005https://conductscience.org/library/papers/16178850PubMed
15959666Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.J Neurol2005https://conductscience.org/library/papers/15959666PubMed
15630455Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?J Clin Invest2005https://conductscience.org/library/papers/15630455PubMed

See all 23 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7584501

GET https://conductscience.org/api/papers/v1/7584501/cited_by?page=2